View |
|
DR-XY40109
|
Zinc Gluconate
|
Solzinc
|
70mg/ 5mL
|
Syrup
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
21 September 2021
|
30 September 2026
|
View |
DR-XY40112_PI_01.pdf
|
DR-XY40112
|
Olmesartan medoxomil + Amlodipine (as besilate) +
Hydrochlorothiazide
|
Tri-Alzor
|
40mg/5mg/ 12.5mg
|
Film-Coated Tablet
|
-
|
Ajanta Pharma Limited
|
India
|
Initial (from Monitored Release)
|
23 June 2023
|
30 September 2024
|
View |
DR-XY40113_PI_01.pdf
|
DR-XY40113
|
Olmesartan medoxomil + Amlodipine (as besilate) + Hydrochlorothiazide
|
Tri-Alzor
|
40mg/10mg/ 12.5mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker Combination
|
Ajanta Pharma Limited
|
India
|
Renewal
|
04 August 2024
|
30 September 2029
|
View |
DR-XY40119_PI_01.pdf
|
DR-XY40119
|
Atorvastatin (As Calcium Propylene Glycol Solvate)
|
Atorvast-Natrapharm
|
80mg
|
Film-Coated Tablet
|
Antihyperlipidemic (HMG CoA reductase inhibitor)
|
Apotex Inc.
|
Canada
|
Initial (from Monitored Release)
|
08 March 2022
|
04 October 2024
|
View |
DR-XY40120_PI_01.pdf
|
DR-XY40120
|
Atorvastatin (as calcium propylene glycol solvate)
|
Atorvast-Natrapharm
|
40mg
|
Film-Coated Tablet
|
Antihyperlipidemic (HMG CoA reductase inhibitor)
|
Apotex Inc.
|
Canada
|
Renewal
|
07 April 2024
|
04 October 2029
|
View |
DR-XY40121_PI_01.pdf
|
DR-XY40121
|
Atorvastatin (As Calcium Propylene Glycol Solvate)
|
Atorvast-Natrapharm
|
20mg
|
Film-Coated Tablet
|
Antihyperlipidemic (HMG CoA reductase inhibitor)
|
Apotex Inc.
|
Canada
|
Initial (from Monitored Release)
|
08 March 2022
|
04 October 2024
|
View |
|
DR-XY40123
|
Vitamin B-Complex + Iron + Lysine + Buclizine HCI
|
Iroplus
|
Formulation Each 5 mL contains: Thiamine Hydrochloride (Vitamin B1) Pyridoxine Hydrochloride (Vitamin B.) Cyanocobalamin (Vitamin B12) Iron L-Lysine Buclizine Hydrochloride
10 mg 5 mg 10 mcg 10 mg (equivalent to 37.91 mg Iron Polymaltose) 125 mg 5
|
Syrup
|
Vitamin/Mineral/Amino Acid/Appetite Stimulant
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
05 August 2021
|
05 October 2026
|
View |
|
DR-XY40125
|
Clozapine
|
Clopax
|
100mg
|
Tablet
|
-
|
Doctors Pharmaceuticals, Inc.
|
Philippines
|
-
|
04 November 2019
|
06 October 2024
|
View |
|
DR-XY40126
|
Cefixime (As Trihydrate)
|
Ofex
|
100mg/5mL
|
Powder For Suspension
|
Antibacterial (Cephalosporin)
|
Delta Pharma, Inc.
|
Bangladesh
|
Automatic Renewal
|
24 June 2021
|
05 October 2026
|
View |
|
DR-XY40127
|
Nalbuphine (as Hydrochloride)
|
Analin
|
20mg/ mL
|
Solution for Injection
|
OPIOID/ANALGESIC
|
Medicaids Pakistan (Private) Limited
|
Pakistan
|
Automatic Renewal
|
19 August 2021
|
05 October 2026
|
View |
|
DR-XY40129
|
METOCLOPRAMIDE (as Hydrochloride)
|
GASTROSIL
|
5mg/5mL
|
Syrup
|
Gastrokinetic (Prokinetic)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
01 April 2022
|
28 October 2026
|
View |
|
DR-XY40130
|
Diphenhydramine Hydrochloride
|
Bexil
|
50mg/ mL
|
Solution for Injection (IM/IV)
|
Antihistamine/Anti-pruritic
|
Zhejiang Ruixin Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal
|
21 September 2021
|
07 October 2026
|
View |
|
DR-XY40131
|
Clonidine (as hydrochloride)
|
Terclodine
|
150 mcg
|
TABLET
|
Alpha-2 Adrenoceptor Agonist
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
20 July 2023
|
07 October 2028
|
View |
|
DR-XY40132
|
Lidocaine Hydrochloride (as monohydrate)
|
EUROCAINE
|
20mg/ mL (2% w/v)
|
Solution for Injection
|
Local Anesthetic/Antiarrhythmic
|
EURO-MED LABORATORIES PHIL., INC.
|
Philippines
|
Automatic Renewal
|
20 July 2021
|
05 October 2026
|
View |
|
DR-XY40137
|
0.9% Sodium Chloride
|
None
|
900 mg/100 mL
|
Solution For IV Infusion
|
-
|
Euro-Med Laboratories Phil., Inc.
|
Philippines
|
-
|
29 July 2020
|
23 September 2025
|
View |
|
DR-XY40140
|
Aceclofenac
|
Zerodol-CR
|
200 mg
|
Controlled-Release Tablet
|
Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
IPCA Laboratories Limited
|
India
|
-
|
03 February 2021
|
05 February 2026
|
View |
|
DR-XY40146
|
Esomeprazole
|
Esofag
|
20mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Micro Labs Limited
|
India
|
Automatic Renewal
|
21 September 2021
|
12 October 2026
|
View |
|
DR-XY40156
|
Metformin Hydrochloride
|
Dimet-850
|
850mg
|
Film-Coated Tablet
|
Oral Hypoglycemic (Biguanide)
|
Oman Pharmaceutical Products Co., L.L.C.
|
Oman
|
Automatic Renewal
|
03 August 2021
|
11 October 2026
|
View |
|
DR-XY40158
|
Ceftazidime (As Pentahydrate)
|
None
|
1g
|
Powder For Injection (IM/IV)
|
-
|
Sinopharm Zhijun (Shenzhen) Pharmaceutical Co.,
|
China
|
-
|
20 November 2020
|
11 October 2025
|
View |
|
DR-XY40171
|
Pioglitazone (As Hydrochloride) + Glimepiride
|
Zoliget
|
15mg/2mg
|
Tablet
|
Blood Glucose-Lowering Drug
|
Getz Pharma (Private Limited
|
Pakistan
|
Automatic Renewal
|
17 July 2021
|
14 October 2026
|